Treatment

EXV-801 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2, PHASE3
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
This study is looking into two new medications, EXV-802 and EXV-801, to see if they can safely and effectively help with agitation (being restless or upset) in people with Alzheimer's disease.
For: Agitation Associated With Alzheimer's Disease Dementia
United States · Canada · United Kingdom